前立腺肥大症に対する脂質代謝改善剤モリステロールの効果

HANDLE Web Site オープンアクセス

書誌事項

タイトル別名
  • Effect of Moristerol (anti-cholesterolemic agent) on benign prostatic hypertrophy
  • ゼンリツセン ヒダイショウ ニ タイスル シシツ タイシャ カイゼンザイ モリ

この論文をさがす

抄録

Moristerol was orally administered in 20 cases of benign prostatic hypertrophy. One capsule of Moristerol contained 200 mg of soysterol . In all the cases, 9 capsules of Moristerol were given per day in three divided doses for 6 weeks. Clinical improvement was observed in 11 of the 20 cases (55%). It consisted mainly of subjective complaints such as improvement of dysuria, narrow and weak urinary stream and feeling of incomplete voiding. As objective findings, a statistically significant decrease of residual urine volume was noted after treatment, although shrinkage of the enlarged prostate was not clear upon palpation or roentgenography. In addition to the improvement of symptoms, serum lipid peroxide which might be considered to be a provocative cause of benign prostatic hypertrophy, was also significantly decreased by Moristerol administration. No marked side effects were seen in this study.

収録刊行物

  • 泌尿器科紀要

    泌尿器科紀要 29 (3), 365-369, 1983-03

    泌尿器科紀要刊行会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ